Regis Stentz is a researcher at Quadram Institute. He is a molecular biologist whose areas of expertise include general microbiology, microbial genetics and biochemistry. He has developed an “in vivo” method for the screening of drug-RNA interactions. This work has pioneered the notion of “riboswitches” and was cited more than 150 times in top quality journals. His previous work at the IFR mainly consisted in studying a chromosomally-integrated conjugative element found in Lactococcus lactis. This work led to the publication of five articles and a patent application.